Current developments of the estimand concept
Pharmaceutical Statistics · 2024-11 · 23 (6) · 864-869
DOI: 10.1002/pst.2395 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutical Statistics, online erschienen am 27.04.2024. Verfasst von Alexander Fierenz und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Hauptthemen laut MEDLINE: Research Design. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft (DFG).
Abstract (Originalsprache)
Since the introduction of the estimand in therapeutical studies, several adaptions have been developed. This short article highlights the important aspects of the estimand concept. A literature research was conducted to identify different extensions to this framework. Different modified strategies for intercurrent events are presented, as well as examples of methods to implement the estimand in clinical studies. The article reflects that the estimand is an ongoing research field with further exploration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
ORCID-Profile: Alexander Fierenz
Förderung
- Deutsche Forschungsgemeinschaft (DFG)
Zitieren
APA
Fierenz, A., & Zapf, A. (2024). Current developments of the estimand concept. Pharmaceutical Statistics, 23(6), 864-869. https://doi.org/10.1002/pst.2395
Vancouver
Fierenz A, Zapf A. Current developments of the estimand concept. Pharmaceutical Statistics. 2024;23(6):864-869. doi:10.1002/pst.2395
BibTeX
@article{Fierenz2024,
author = {Fierenz, Alexander and Zapf, Antonia},
title = {Current developments of the estimand concept},
journal = {Pharmaceutical Statistics},
year = {2024},
volume = {23},
number = {6},
pages = {864--869},
doi = {10.1002/pst.2395}
}
EUVIMED